Literature DB >> 28449523

What could be the key elements to determine the optimal number of lymph nodes sampled?

Yoshihisa Shimada1.   

Abstract

Year:  2017        PMID： 28449523      PMCID： PMC5394011          DOI： 10.21037/jtd.2017.03.49

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread.

Authors:  Shun-ichi Watanabe; Hisao Asamura; Kenji Suzuki; Ryosuke Tsuchiya
Journal:  Interact Cardiovasc Thorac Surg       Date:  2005-01-27

2.  Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Keizo Misumi; Takuhiro Ikeda; Takeshi Mimura; Jun Hihara; Morihito Okada
Journal:  Jpn J Clin Oncol       Date:  2011-05-25       Impact factor: 3.019

3.  Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Authors:  Yasuhiro Tsutani; Yoshihiro Miyata; Haruhiko Nakayama; Sakae Okumura; Shuji Adachi; Masahiro Yoshimura; Morihito Okada
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-20       Impact factor: 5.209

4.  Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.

Authors:  Morihito Okada; Toshihiko Sakamoto; Tsuyoshi Yuki; Takeshi Mimura; Hiroyuki Nitanda; Kei Miyoshi; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

5.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

6.  Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?

Authors:  Elizabeth A David; David T Cooke; Yingjia Chen; Kieranjeet Nijar; Robert J Canter; Rosemary D Cress
Journal:  Ann Thorac Surg       Date:  2016-07-26       Impact factor: 4.330

7.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.